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ABSTRACT 
Patient adherence is a key factor that determines the 
outcome of diabetes mellitus therapy. This study was conducted 
to determine the effect of a medication reminder chart on level 
adherence and clinical outcome in patients with Type 2 diabetes 
mellitus. The experimental study used pretest-posttest design 
with control group was conducted during February until April of 
2016 at Sleman Hospital in Yogyakarta. Patients were 
categorized into two groups of different subjects, who received of 
medication reminder chart tools were 40 patients (Code A) and 
the other 40 patients were assigned to control group (Code B). 
Morisky Medication Adherence Scale of 8-item (MMAS-8) was 
used to measure adherence. Clinical outcome were measured 
based on FBG decrease (mg/dl). Two independent sample t-test 
was using to determine the mean differences of the average 
score of the adherence level before and after using the 
medication reminder chart.  The results of this study showed that 
Medication Reminder Chart compared control groups improved 
adherence (p=0.000) but did not improve clinical outcome 
(p=0.411). The pharmacist might use The Medication Reminder 
Chart to improve medication adherence for chronic disease. 
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INTRODUCTION 
Diabetes mellitus was in the list of top 
10 highest prevalence disease in Sleman 
(Dinkes Sleman, 2013). The type 2 of diabetes 
mellitus is one of metabolic disease with 
increasing prevalence over years, which one 
cause lower limb amputations, blindness, and 
kidney failure in 20-74 years old (CDC, 2009). 
The type 2 diabetes mellitus was chronic 
metabolic disease with multiple etiology 
characterized by hyperglycemia and impaired 
metabolism of carbohydrates, lipids and 
proteins as a result of insufficiency of insulin 
function. Insufficiency of insulin function is 
known to be caused by impaired or deficient 
production of insulin with beta cells 
Langerhans of the pancreas gland, or due to 
reduced the responsiveness of cells on insulin 
(Wells et al., 2009). 
Patients who are non adherence to 
treatment could make serious problem and are 
great challenge in making a treatment succeed. 
The success of treatment is not only adherence, 
but included also monitoring of blood glucose, 
dietary changes, care of foot hygene, and 
exercise (Santosa, 2011). Inadherence is 
suspected to be caused by factors related to the 
patient such as age, gender, education or related 
therapy patient as long diagnostics, complexity 
of treatment and side effects of drugs (Divya 
and Nadig, 2015). Based on the WHO report 
of 2003, the average long-term treatment of 
adherence in chronic diseases in developed 
countries reached 50%, while in developing 
countries is lower (Cramer, 2004). The study in 
Sudan, showed that medications adherence was 
100 (44.2%) for patients on oral medications 
and 57 (45.6%) for insulin users (El-Hadiyah et 
al., 2016). The success of treatment in type 2 
diabetes mellitus was influenced by patient 
adherence in taking medicine (BPOM, 2006) 
One of the instruments used to assess 
the adherence patients with type 2 diabetes 
mellitus is the Morisky Medication Adherence 
Scale (MMAS-8) with eight item questionnaire 
developed by Morisky et al., (2008). This 
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questionnaire has been evaluated with high 
reliability (0.83), high sensitivity and specificity 
(Morisky et al., 2008). Another method for 
assessing adherence was  pill count. Pill count 
was known to have high accuracy (Lam and 
Paula, 2015). 
In this study, Medication Reminder 
Chart tools used to improve patient adherence 
with medication use. This method was chosen 
because it offers cheap, easy method that had 
proven its capability to improve adherence with 
medication use (Conn et al., 2009). 
 
MATERIAL AND METHODS 
Subjects research 
Subjects were outpatients with type 2 
diabetes mellitus with complication such are 
hypertension, dislipidemia, neuropathy diabetic, 
and chronic heart failure. The study begin in 
February until March of 2016 at Sleman 
Hospital in Yogyakarta. The total number of 
patients is 80. The number of subjects was 
obtained from sample size calculation in 
experimental studies, where the outcome 
varians (σ2) is 47,82 and µ1  -µ2  are 158,0 – 126,9 
that  were obtained from research conducted 
by Wishah et al., (2015) and the results obtained 
from sample size calculation in this study is 29 
patients, typically added 20% to avoid drop out 
(29 + 6 = 35 patients), so in this study required 
minimal of 35 subjects of each groups. The 
subjects were divided into two groups. The first 
group was given the intervention of Medication 
Reminder Chart which consisted of 40 patients 
and control group consisted of 40 patients. 
Inclusion criteria were patients who was 
diagnosed with type 2 diabetes mellitus or with 
complication, subjects  ≥ 26 years old, fasting 
blood glucose ≥ 100 mg / dl, patients 
adherence with scale of MMAS  less than 8, 
patients who never used Medication Reminder 
Chart before, willing to participate in the study 
by signing an informed consent. Exclusion 
criteria were pregnant patients.  
The Medication Reminder Chart is a tool 
or medical records used by patients after taking 
medication. The part of medication reminder 
consists of drugs name, indication, and the 
strength of doses were designed by researchers 
with reference to the meta-analysis which is  
conducted by Conn et al., (2009). Medication 
reminder chart is benefecial for patients who 
have gotten complex treatment, as well as 
useful for patients who use one or two of           
drug with specific problems when the patients 
has activity outside or difficulty to remember 
taking medication at a certain time (Raynor, 
2011).  
 
Research data 
Data obtained from medical records 
included age, gender, education and 
employment history, body mass index, long 
term diagnose, smoking history, comorbid, diet 
of carbohydrate, type of treatment, physical 
exercise,  fasting blood glucose level and 
interviewed with patients included using of 
Morisky Medication Adherence Scale 
Questionnaire with eight items questionnaire 
and pill count. Data were obtained 
prospectively and sampling methods using 
random allocation sampling determined with 
random numbers (0-99) with 6 bloks sequences 
patterns A and B, A code assiegned for 
Medication Reminder Chart and B for Control 
groups, randomization was done using 
Microsoft Excel.  
Adherence of patients was evaluated by 
MMAS-8 questionnaire cales that categorize 
patients into three categories of adherence. The 
first one was high adherence patients with a 
score of 8 on the scale, medium adherence   
with a score of 6-7, and low adherence with a 
score < 6 (Morisky et al., 2008). Therapy 
outcome of fasting blood glucose level 
measuring before and after intervention. 
Expected therapy goal of fasting blood glucose 
is  < 110mg/dL.  
 
Analysis of research finding 
Patients was classified by age, gender, 
education and employment history, type of 
treatment, body mass index, long term 
diagnose, smoking history, comorbid, diet of 
carbohydrate, physical exercise were analyzed 
with Chi-Square statistic to investigate whether 
distributions of categorical variables differ from 
one another. The adherence with MMAS-8 
questionnaire and clinical outcome were 
determined before and after treatment. 
Kolmogorov smirnov test is used to evaluate 
the variable data is sufficiently normal.              
The adherence scale (MMAS-8) question-          
naire   and   clinical  outcome  (FBG)  (mg/dl).  
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Data pairs which were not normally distributed 
were analyzed with Two Independent samples 
t-test (Wilcoxon), while paired data which were 
normally distributed were analyzed with Two 
Independent samples t-test (Mann-Whitney). 
 
RESULTS AND DISCUSSIONS 
Patient  characterstics 
Characteristics of subjects in this study 
was analyzed to determine the proportions 
between the treatment group and control in 
baseline conditions (Table I).  
The results from whole characteristics 
data analysis upon the two study groups 
insignificant value of p>0.05, with similar 
proportion between the two groups. 
Characteristic data of the subjects age            
showed significant value of p<0.05, which 
showed different proportion between two 
groups. 
 
Identification of adherence with pill 
count after treatment 
Table II showed that pill count analysis 
result was categorized into two groups. The 
first group for adherent patients with score of 
80-100% and non-adherent patients with score  
under 80%. 
Table  I. Characteristics data of medication reminder chart and control groups 
 
Characteristics 
Medication Reminder 
Chart n  (%) 
Control 
n  (%) 
Total Subject 
n  (%) 
p 
value 
Gender 
Male 13 (32.5) 14(35) 27(33.75) 
53(66.25) 
0.813a 
Female 27 (67.5) 26(65) 
Age 
Adult 28(70) 19 (47.5) 47(58.75) 
0.041a 
Elderly 12 (30) 21 (52.5) 33(41.25) 
Body weight 
Underweight 2 (5) 1 (2.5) 3 (3.75) 
0.747a Normal weight 18 (45) 19 (47.5) 37 (46.25) 
Overweight 20 (50) 20 (50) 40 (50) 
Education 
Uneducated 
Elementary 
High School 
1(2,5) 
13(32,5) 
26 (65) 
1(2.5) 
16 (40) 
23 (57.5) 
2(2.5) 
29(36.25) 
49 (61.25) 
0.508a 
 
Table  II. Characteristics data of medication reminder chart and control groups 
 
Characteristics 
Medication Reminder 
Chart n  (%) 
Control 
n  (%) 
Total Subject  
n  (%) 
p 
value 
Occupation 
Occupied 18 (45) 14 (35) 32 (40) 
0.361a 
Not occupied 22  (55) 26 (65) 48 (60) 
Carbohydrate  Controlled 23 (57.5) 25 (62.5) 48 (60) 
0.648a 
Diet Uncontrolled 17 (42.5) 15 (37.5) 32(40) 
Physical exercise 
Regular 3 (7.5) 1 (2.5) 4(5) 
0.308a 
Not regular 37 (92.5) 39 (97.5) 76 (95) 
Smoking 
Yes 4 (10) 7 (17.5) 11(13.75) 
0.330a 
No 36 (90) 33 (82.5) 69(86.25) 
Diagnosed for < 1 year 3(7.5) 7(17.5) 10 (12.5) 
0.369a 
DM 
1 – 5 years 11(27.5) 11(27.5) 22(27.5) 
< 5 years 26(65) 22(55) 48(60) 
Comorbid 
DM  10(25) 7 (17.5) 17(21.25) 
0.160a DM + HT 21(52.5) 16 (40) 37 (46.25) 
DM + others 9 (22.5) 17 (42.5) 26(32.5) 
Prescription of  
antidiabetic  
Single 15(37.5) 15 (37.5) 30(37.5) 
1.0a 
Combined 25 (62.5) 25(62.5) 50(62.5) 
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Profile of patient adherence by pill count 
of Medication Reminder Chart group was 
higher with percentage of 52.5%, compared to 
control groups with percentage of 47.5% 
(Table III). 
 
The effect of medication reminder chart 
to patient adherence 
Blood glucose control was significantly 
associated with adherence to treatment thus 
reducing the complications of diabetes, 
hospitalizations, costs, and mortality.  Medication 
Reminder Chart was effective in improving 
patient adherence with risk of therapy 
regiments complexity (Manmohan et al., 2012). 
The Median difference of adherence measured 
with MMAS-8 score of Medication Reminder 
Chart and control group, in this study using a 
non-parametric analysis with Two Independent 
Samples test (Mann-Whitney) for data unpaired 
groups (Table IV). 
A significant effect of Medication 
Reminder Chart to increase adherence of 
MMAS-8 score from pre-test to post-test 
higher than control group with p value p=0.000 
and median different of 0.5. This study same as 
the research conducted by Conn et al which 
shown that  intervention of Medication 
Reminder Chart could improve adherence, 
especially in elderly patients in treatment (Conn 
et al., 2009) (Table IV) . 
 
The effect of medication reminder chart 
on clinical outcome 
One of the key factors to achieve 
therapeutic goals is patient adherence. Low 
adherence could affect bad clinical outcome. 
Optimal adherence of tretament would 
succesesfully improve therapeutic efficacy in 
the treatment of all chronic diseases and 
improved quality of life patients (Santosa, 
2011). The Median different of clinical 
outcome in Medication Reminder Chart and 
control group (Table IV). 
The result form table IV showed 
insignificant effect of Medication Reminder 
Chart compared to control groups in the 
decrease of fasting blood glucose level in type 2 
diabetes mellitus patients with p value p=0.411 
and median difference of 5.5. Basically the 
improvement of clinical outcomes affected by 
increased adherence, which in this study was 
measured based on interviews with 
questionnaires MMAS-8. The results showed 
patients adherence was increased after giving 
medication reminder chart, but even with 
increased adherence, the number of forgetting 
patients greater in adult category which was 
caused by being busy on working that 
sometimes lead them to be forgotten to take 
medication. Other than that, based on the 
results of interviews, some patients forgot to fill 
medication Reminder Chart after taking 
medication because of being busy, while others 
were not filling the medication Reminder Chart 
because they assumed that they know the 
schedule for taking the medication (thinks that 
filling the chart was not important), and others 
consider medication Reminder Chart is needed 
to help them remember the schedule for taking 
the  medication  and  could   be  disciplined  in 
Table III. Profile of patient adherence with pill count 
 
Patients adherence profile 
Medication Reminder Chart Control  
N % N % 
Adherent 21 52.5 15 37.5 
Non adherent 19 47.5 25 62.5 
 
Table IV. The median difference of adherence effect measured with MMAS-8 score of medication 
reminder chart and control groups. 
  
Grouping Median (Maximum-Minimum) p value Median different 
Medication Reminder Chart 1.50  (3-0) 0.000a 0.5 
Control 1.00 (3-0)   
 
 
Yunita Suffiana 
Volume 28 Issue 2 (2017)  129 
taking medicine. Therefore it is considered 
important to inform patients to use medication 
Reminder Chart to improve adherence. The 
results of the analysis showed the correlation 
between adherence and clinical outcomes in 
patients with Type 2 diabetes (Table V).   
Correlation between adherence and FBG 
levels with a significance p=0.029, and positive 
correlation coefficient of (r=0.213), it means 
that higher adherence would increase the 
clinical outcome, the strength of the correlation 
is weak (r=0.2- < 0.4), which indicated  while 
the correlation was positive, but compared to 
the clinical outocme between the two groups, it 
could not significantly decrease fasting blood 
glucose level after Medication Reminder Chart 
(Table VI). 
The success of treatment was not 
completely influenced by adherence of drug 
use. The success of therapy in type 2 diabetes 
mellitus could be improved by controlling the 
diet, monitor blood glucose levels and exercise 
(Santosa, 2011). 
 
CONCLUSION 
Medication Reminder Chart could 
improve adherence of patients compared to 
control group in Type 2 diabetes mellitus 
patients (p = 0.000) with median difference of 
0.5. Medication Reminder Chart could not 
improve clinical outcomes in treatment group 
compared to control groups in patients with 
Type 2 diabetes mellitus (p = 0.411) with 
median difference of 5.5. Increased compliance 
could increased clinical outcome (p = 0.029), 
with a positive correlation and the strength of 
weak correlation (r = 0.213). 
 
LIMITED STUDY AND SUGGESTION 
Many factors can not be controlled in  
type 2 diabetes mellitus  outpatient such as diet, 
excercise etc. Required modifications 
Medication Reminder Chart more informative 
(name of medication, dosage, frequency of use, 
indications, schedule for taking medication) and 
the instructions for filling the sheet of  
Medication Reminder Chart. 
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